Michael Bryan Roe

Title: Michael Bryan Roe: Innovator in Pharmaceutical Dosage Forms

Introduction

Michael Bryan Roe is a notable inventor based in Wiltshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral solid dosage forms. His work focuses on innovative solutions that enhance the efficacy of medications.

Latest Patents

Michael Bryan Roe holds a patent for "Dosage forms comprising a plasma kallikrein inhibitor." This invention relates to oral solid dosage forms that include a plasma kallikrein inhibitor, specifically a solid form (Form 1) of the compound of Formula A. The patent also outlines methods for preparing these oral solid dosage forms using Form 1 of the compound of Formula A. This innovation is crucial for improving the delivery and effectiveness of therapeutic agents.

Career Highlights

Michael is currently associated with Kalvista Pharmaceuticals Limited, where he applies his expertise in pharmaceutical formulations. His work at Kalvista Pharmaceuticals has positioned him as a key player in the development of advanced drug delivery systems. His dedication to innovation in this field is evident through his patent and ongoing research efforts.

Collaborations

Michael has collaborated with esteemed colleagues, including John Herman Collett and Gary Paul Cook. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical science.

Conclusion

Michael Bryan Roe's contributions to the field of pharmaceuticals, particularly through his patent on plasma kallikrein inhibitors, highlight his role as an innovator. His work continues to influence the development of effective oral solid dosage forms, showcasing the importance of innovation in healthcare.